13F

Stock

Spyre Therapeutics, Inc.

SYRE · held by 1 managers

Reported value

$3.24M

Holders

1

+0 new · −0 exited

Holders’ est. mark

−$250K

Price effect on 1 books still in the name

Largest holder

$3.24M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC216.6K$3.24M−$250KCut−$219.5K

Positions as of Q2 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.